Asthma and atopy in COVID-19: 2021 updates.

Carr, Tara F; Kraft, Monica

Carr, Tara F; Kraft, Monica.

Carr TF; Asthma and Airway Disease Research Center, Department of Medicine, University of Arizona, Tucson, Ariz. Electronic address: TCarr@deptofmed.arizona.edu.
Kraft M; Asthma and Airway Disease Research Center, Department of Medicine, University of Arizona, Tucson, Ariz.

J Allergy Clin Immunol ; 149(2): 562-564, 2022 02.

Article in English | MEDLINE | ID: covidwho-1587445

Subject(s)

Anti-Asthmatic Agents/therapeutic use; Asthma/immunology; COVID-19/immunology; Glucocorticoids/therapeutic use; SARS-CoV-2/pathogenicity; Asthma/complications; Asthma/mortality; Asthma/virology; COVID-19/complications; COVID-19/mortality; COVID-19/virology; Humans; Nasopharynx/immunology; Nasopharynx/virology; Severity of Illness Index; Survival Analysis

Keywords

Asthma; COVID-19 disease; SARS-CoV-2; atopy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Asthma / Anti-Asthmatic Agents / SARS-CoV-2 / COVID-19 / Glucocorticoids Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: J Allergy Clin Immunol Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google